Viatris Inc. (LON:0A5V)

London flag London · Delayed Price · Currency is GBP · Price in USD
9.05
+0.00 (0.02%)
At close: Jul 16, 2025
-19.34%
Market Cap8.11B
Revenue (ttm)11.09B
Net Income (ttm)-2.93B
Shares Outn/a
EPS (ttm)-2.46
PE Ration/a
Forward PE4.11
Dividend0.37 (4.07%)
Ex-Dividend DateMay 23, 2025
Volume3,455
Average Volume4,716
Open8.90
Previous Close9.05
Day's Range8.73 - 9.06
52-Week Range6.91 - 13.54
Betan/a
RSI58.24
Earnings DateAug 7, 2025

About Viatris

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers prescription brand drugs, generic drugs, complex generic drugs, and biosimilars. It also provides drugs in various therapeutic areas covering various noncommunicable and infectious diseases, including cardiovascular, CN... [Read more]

Industry Pharmaceutical Preparations
Founded 1961
Employees 32,000
Stock Exchange London Stock Exchange
Ticker Symbol 0A5V
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.